| There’s new data about patients’ experiences with hemophilia |
|
|
|
| A new survey paints a vivid picture of the challenges hemophilia patients face. The results may help you understand your patients’ challenges and concerns related to: |
 |
|
Bleed protection |
 |
|
Administration |
 |
|
Postponing, delaying, or missing treatment |
 |
|
Physical and emotional burdens of treatment |
 |
|
And other aspects of life with hemophilia |
|
|
|
|
|
| Research into anticoagulant inhibition |
| Scientists are researching different ways to approach the coagulation cascade. Learn more about this research—you can also watch a video about the coagulation cascade. |
 |
|
|
|
|
|
|
|
| Different administration options are being researched, too |
| The survey described above illustrates patients’ experiences with their current hemophilia therapy, including data on challenges related to administration. Scientists are currently researching different approaches to administration that may be of interest to you. |
|
|
|
|
| Stay in the know |
| Keep up to date with the latest in hemophilia research. |
|
|
|
 |
|
|
|
| Please do not respond to this email. If you would like to contact us, please click here or call 1‑800-727-6500. |
| UNSUBSCRIBE NOTICE |
| If you no longer want to receive communications from Novo Nordisk, click here to unsubscribe. You also may call us at 1-877-744-2579 or send us a letter that includes your full contact information (eg, name, email address, phone) to Novo Nordisk, 800 Scudders Mill Road, Plainsboro, New Jersey 08536. To better understand how Novo Nordisk values your privacy, see our Privacy Statement. |
|
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2023 Novo Nordisk All rights reserved. US22HRBD00221 April 2023 |
 |
|
|
|
